← FDA Drug Approvals (Drugs@FDA)

GRISEOFULVIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS MID ATLANTIC · Approved 2007-07-06

Drug application

FDA Application #

ANDA065394

Application type

Abbreviated New Drug Application (Generic)

Brand name

GRISEOFULVIN

Generic name

GRISEOFULVIN

Active ingredients

GRISEOFULVIN, MICROSIZE

Dosage form

SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

ACTAVIS MID ATLANTIC

Manufacturer

Actavis Pharma, Inc.

First approval

2007-07-06

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown